As of 2024-12-14, the Relative Valuation of Spago Nanomedical AB (publ) (SPAGO.ST) is (3.03) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 0.18 SEK, the upside of Spago Nanomedical AB (publ) based on Relative Valuation is -1813.8%.
The range of the Relative Valuation is (2.60) - (3.08) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.3x - 31.7x | 31.6x |
| Forward P/E multiples | 21.5x - 29.9x | 27.3x |
| Fair Price | (2.60) - (3.08) | (3.03) |
| Upside | -1571.1% - -1838.8% | -1813.8% |
| Date | P/E |
| 2024-12-13 | -1.72 |
| 2024-12-12 | -1.74 |
| 2024-12-11 | -1.72 |
| 2024-12-10 | -1.65 |
| 2024-12-09 | -1.72 |
| 2024-12-06 | -1.67 |
| 2024-12-05 | -1.75 |
| 2024-12-04 | -1.71 |
| 2024-12-03 | -1.75 |
| 2024-12-02 | -1.71 |
| 2024-11-29 | -1.68 |
| 2024-11-28 | -1.77 |
| 2024-11-27 | -1.81 |
| 2024-11-26 | -1.79 |
| 2024-11-25 | -1.84 |
| 2024-11-22 | -1.91 |
| 2024-11-21 | -1.84 |
| 2024-11-20 | -1.84 |
| 2024-11-19 | -1.83 |
| 2024-11-18 | -1.91 |
| 2024-11-15 | -2.04 |
| 2024-11-14 | -1.89 |
| 2024-11-13 | -1.93 |
| 2024-11-12 | -1.88 |
| 2024-11-11 | -1.94 |
| 2024-11-08 | -2.06 |
| 2024-11-07 | -1.90 |
| 2024-11-06 | -1.94 |
| 2024-11-05 | -1.94 |
| 2024-11-04 | -2.14 |
| 2024-11-01 | -2.04 |
| 2024-10-31 | -2.10 |
| 2024-10-30 | -2.10 |
| 2024-10-29 | -2.06 |
| 2024-10-28 | -1.98 |
| 2024-10-25 | -2.06 |
| 2024-10-24 | -2.14 |
| 2024-10-23 | -2.16 |
| 2024-10-22 | -2.14 |
| 2024-10-21 | -1.98 |
| 2024-10-18 | -2.19 |
| 2024-10-17 | -2.14 |
| 2024-10-16 | -2.23 |
| 2024-10-15 | -2.25 |
| 2024-10-14 | -2.17 |
| 2024-10-11 | -2.25 |
| 2024-10-10 | -2.23 |
| 2024-10-09 | -2.31 |
| 2024-10-08 | -2.31 |
| 2024-10-07 | -2.25 |